Skip to main content
. 2021 Jan 19;10(3):e019669. doi: 10.1161/JAHA.120.019669

Figure 1. Odds ratio (95% CI) of COVID‐19 infection associated with antihypertensive drug exposure stratified by sex, age, race/ethnicity, and comorbidities after propensity score matching.

Figure 1

A, P‐interaction <0.05 for age‐stratified analysis. A through C, Additional variables included in the model after propensity score matching: age, sex, race/ethnicity, and covariates with standardized mean difference >0.1 (Figures S3 through S5). ACEI indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; BB, beta blocker; CCB, calcium channel blocker; CKD, chronic kidney disease; and COVID‐19, coronavirus disease 2019.